Tilos Therapeutics Headquarters
Looking for information about Tilos Therapeutics Headquarters? The links below have collected all the necessary data.
Tilos Therapeutics - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/tilos-therapeutics
- Tilos Therapeutics is developing antibody therapeutics that target key immunological pathways, with a primary focus on regulatory T cells and regulation of effector cells. The company's initial work is on antibodies specific for Latency Associated Peptide of TGF beta. Tilos was founded in 2016 and is based in Cambridge, Massachusetts.Founded: 2016
Tilos Therapeutics Inc - Company Profile and News ...
- https://www.bloomberg.com/profile/company/1440049D:US
- Tilos Therapeutics, Inc. operates as a biotechnology company. The Company offers antibodies for the treatment of cancer, fibrosis, and autoimmune diseases.Founded: Feb 02, 2016
Tilos Therapeutics - Hereva Consultants Inc.
- https://hereva.com/work/tilos-therapeutics/
- About the project. Founded in 2016, Tilos Therapeutics rapidly outgrew the shared facilities at Lab Central, Cambridge MA. The new Headquarters located at Hayden Research Campus in Lexington MA, provided the square footage and was the ideal opportunity to fit out laboratory and offices specifically designed to meet their needs.Estimated Reading Time: 3 mins
Tilos Therapeutics Company Profile: Acquisition ...
- https://pitchbook.com/profiles/company/169143-85
- Tilos Therapeutics General Information Description. Developer of antibody therapeutics designed to treat cancer, fibrosis and related disorders. The company's antibody therapeutics harnesses the power of the immune system to develop new therapies that target key immunological pathways with a primary focus on regulatory T cells and regulation of effector cells, enabling patients to start ...
Tilos Therapeutics, Inc.
- https://www.hereva.com/wp-content/uploads/2020/06/Project-Profiles-2020-Tilos.pdf
- Founded in 2016, Tilos Therapeutics rapidly outgrew the shared facilities at Lab Central, Cambridge MA. The new Headquarters located at Hayden Research Campus in Lexington MA, provided the square footage and was the ideal opportunity to fit out laboratory …
Merck to Acquire Tilos Therapeutics - Merck.com
- https://www.merck.com/news/merck-to-acquire-tilos-therapeutics/
- Jun 10, 2019 · Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that it has entered into a definitive agreement to acquire Tilos Therapeutics, a privately held biopharmaceutical company developing therapeutics targeting the latent TGFβ complex for the treatment of cancer, fibrosis and autoimmune diseases. “At Merck we continue to enhance our robust …
Merck to acquire Tilos Therapeutics for up to $773m
- https://www.pharmaceutical-technology.com/news/merck-acquires-tilos-therapeutics/
- Merck to acquire Tilos Therapeutics for $773m. 11 Jun 2019. Merck has signed an agreement to buy biopharmaceutical company Tilos Therapeutics for a total consideration of up to $773m. Tilos Therapeutics aims to offer therapies for patients with cancer, fibrosis and autoimmune diseases. Credit: Amanda Jones on Unsplash.
Merck to acquire Tilos Therapeutics, in a bet on cancer ...
- https://www.statnews.com/2019/06/10/merck-to-acquire-boston-area-immunotherapy-startup-for-up-to-770-million/
- Jun 10, 2019 · M erck ( MRK) announced Monday that it would acquire Tilos Therapeutics for up to $770 million, a potentially massive windfall for a 3-year-old …
Have you found Tilos Therapeutics Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.